Saliva As a Biological Fluid in SARS-CoV-2 Detection

Background: The polymerase chain reaction of upper respiratory tract swab samples was established as the gold standard procedure for diagnosing SARS-CoV-2 during the COVID pandemic. However, saliva collection has attracted attention as an alternative diagnostic collection method. The goal of this study was to compare the use of saliva and nasopharyngeal swab (NPS) samples for the detection of SARS-CoV-2.

Methods: Ninety-nine paired samples were evaluated for the detection of SARS-CoV-2 by saliva and swab for a qualitative diagnosis and quantitative comparison of viral particles. Furthermore, the detection limits for each sample collection technique were determined. The cycle threshold (C) values of the saliva samples, the vaccination status, and the financial costs associated with each collection technique were compared.

Results: The results showed qualitative equivalence in diagnosis (96.96%) comparing saliva and swab collection, although there was low quantitative agreement. Furthermore, the detection limit test demonstrated equivalence for both collection methods. We did not observe a statistically significant association between C values and vaccination status, indicating that the vaccine had no influence on viral load at diagnosis. Finally, we observed that the use of saliva incurs lower financial costs and requires less use of plastic materials, making it more sustainable.

Conclusions: These findings support the adoption of saliva collection as a feasible and sustainable alternative to the diagnosis of COVID-19.

References

Johnson A, Zhou S, Hoops S, Hillmann B, Schomaker M, Kincaid R . Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19. Microbiol Spectr. 2021; 9(1):e0008621. PMC: 8552797. DOI: 10.1128/Spectrum.00086-21. View

Nasiri K, Dimitrova A . Comparing saliva and nasopharyngeal swab specimens in the detection of COVID-19: A systematic review and meta-analysis. J Dent Sci. 2021; 16(3):799-805. PMC: 7846225. DOI: 10.1016/j.jds.2021.01.010. View

Fernandes Matuck B, Dolhnikoff M, Duarte-Neto A, Maia G, Gomes S, Sendyk D . Salivary glands are a target for SARS-CoV-2: a source for saliva contamination. J Pathol. 2021; 254(3):239-243. PMC: 8250228. DOI: 10.1002/path.5679. View

Saluzzo F, Mantegani P, Poletti de Chaurand V, Cugnata F, Rovere-Querini P, Cilla M . Saliva molecular testing for SARS-CoV-2: simplifying the diagnosis without losing accuracy. Eur Respir J. 2021; 58(6). PMC: 8859976. DOI: 10.1183/13993003.02099-2021. View

de Santi C, Jacob B, Kroich P, Doyle S, Ward R, Li B . Concordance between PCR-based extraction-free saliva and nasopharyngeal swabs for SARS-CoV-2 testing. HRB Open Res. 2021; 4:85. PMC: 8408542. DOI: 10.12688/hrbopenres.13353.2. View

Pasomsub E, Watcharananan S, Watthanachockchai T, Rakmanee K, Tassaneetrithep B, Kiertiburanakul S . Saliva sample pooling for the detection of SARS-CoV-2. J Med Virol. 2020; 93(3):1506-1511. PMC: 7461487. DOI: 10.1002/jmv.26460. View

Azzi L, Dalla Gasperina D, Veronesi G, Shallak M, Ietto G, Iovino D . Mucosal immune response in BNT162b2 COVID-19 vaccine recipients. EBioMedicine. 2021; 75:103788. PMC: 8718969. DOI: 10.1016/j.ebiom.2021.103788. View

Pratelli A, Lucente M, Mari V, Cordisco M, Sposato A, Capozza P . A simple pooling salivary test for SARS-CoV-2 diagnosis: A Columbus' egg?. Virus Res. 2021; 305:198575. PMC: 8454190. DOI: 10.1016/j.virusres.2021.198575. View

Peterson K, Snyder J, Despres H, Schmidt M, Eckstrom K, Unger A . Determining the impact of vaccination on SARS-CoV-2 RT-PCR cycle threshold values and infectious viral titres. Access Microbiol. 2023; 5(10). PMC: 10634488. DOI: 10.1099/acmi.0.000597.v3. View

10.

Sagredo-Olivares K, Morales-Gomez C, Aitken-Saavedra J . Evaluation of saliva as a complementary technique to the diagnosis of COVID-19: a systematic review. Med Oral Patol Oral Cir Bucal. 2021; 26(4):e526-e532. PMC: 8254882. DOI: 10.4317/medoral.24424. View

11.

Herrera L, Hidalgo-Miranda A, Reynoso-Noveron N, Meneses-Garcia A, Mendoza-Vargas A, Reyes-Grajeda J . Saliva is a reliable and accessible source for the detection of SARS-CoV-2. Int J Infect Dis. 2021; 105:83-90. PMC: 7876483. DOI: 10.1016/j.ijid.2021.02.009. View

12.

Pierri B, Tafuro M, Cuomo M, Di Concilio D, Vassallo L, Pierri A . Assessment of Saliva Specimens' Reliability for COVID-19 Surveillance. Front Public Health. 2022; 10:840996. PMC: 9015071. DOI: 10.3389/fpubh.2022.840996. View

13.

Teo A, Choudhury Y, Tan I, Cher C, Chew S, Yi Wan Z . Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection. Sci Rep. 2021; 11(1):3134. PMC: 7862309. DOI: 10.1038/s41598-021-82787-z. View

14.

McPhillips L, MacSharry J . Saliva as an alternative specimen to nasopharyngeal swabs for COVID-19 diagnosis: Review. Access Microbiol. 2022; 4(5):acmi000366. PMC: 9394527. DOI: 10.1099/acmi.0.000366. View

15.

Tutuncu E, Ozgur D, Karamese M . Saliva samples for detection of SARS-CoV-2 in mildly symptomatic and asymptomatic patients. J Med Virol. 2021; 93(5):2932-2937. PMC: 8013767. DOI: 10.1002/jmv.26821. View

16.

Giron-Perez D, Ruiz-Manzano R, Benitez-Trinidad A, Ventura-Ramon G, Covantes-Rosales C, Ojeda-Duran A . Saliva Pooling Strategy for the Large-Scale Detection of SARS-CoV-2, Through Working-Groups Testing of Asymptomatic Subjects for Potential Applications in Different Workplaces. J Occup Environ Med. 2021; 63(7):541-547. PMC: 8247539. DOI: 10.1097/JOM.0000000000002176. View

17.

Komiazyk M, Walory J, Gawor J, Ksiazek I, Gromadka R, Baraniak A . Case Report of COVID-19 after Full Vaccination: Viral Loads and Anti-SARS-CoV-2 Antibodies. Diagnostics (Basel). 2021; 11(10). PMC: 8534434. DOI: 10.3390/diagnostics11101815. View

18.

Hur K, Park K, Lim Y, Jeong Y, Sung H, Kim M . Evaluation of Four Commercial Kits for SARS-CoV-2 Real-Time Reverse-Transcription Polymerase Chain Reaction Approved by Emergency-Use-Authorization in Korea. Front Med (Lausanne). 2020; 7:521. PMC: 7438443. DOI: 10.3389/fmed.2020.00521. View

19.

Eduardo F, Bezinelli L, de Araujo C, Moraes J, Birbrair A, Pinho J . Self-collected unstimulated saliva, oral swab, and nasopharyngeal swab specimens in the detection of SARS-CoV-2. Clin Oral Investig. 2021; 26(2):1561-1567. PMC: 8360804. DOI: 10.1007/s00784-021-04129-7. View

20.

Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S . SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181(2):271-280.e8. PMC: 7102627. DOI: 10.1016/j.cell.2020.02.052. View